RISPERIDONE-CHANELLE ORAL SOLUTION 1 MG/ML
Product details
Registration number: SIN15227P
Classification: Prescription Only
Active ingredients: RISPERIDONE
Strength: 1mg/ml
Dosage form: SOLUTION
Route: ORAL
Registrant: MEDICELL PHARMACEUTICAL (S) PTE. LTD.
ATC code: N05AX08
HSA approval date: 26 April 2017
Manufacturer(s): Dar Al Dawa Development and Investment Co Ltd
Manufacturing country/countries: JORDAN
What are the HSA registration number and classification for RISPERIDONE-CHANELLE ORAL SOLUTION 1 MG/ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15227P
Classification: Prescription Only
What active ingredients and strength are recorded for RISPERIDONE-CHANELLE ORAL SOLUTION 1 MG/ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: RISPERIDONE
Strength: 1mg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for RISPERIDONE-CHANELLE ORAL SOLUTION 1 MG/ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: SOLUTION
Route: ORAL
Who is the recorded registrant for RISPERIDONE-CHANELLE ORAL SOLUTION 1 MG/ML?
According to the HSA dataset updated 7 August 2026:
Registrant: MEDICELL PHARMACEUTICAL (S) PTE. LTD.
Which manufacturers and countries are listed for RISPERIDONE-CHANELLE ORAL SOLUTION 1 MG/ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Dar Al Dawa Development and Investment Co Ltd
Manufacturing country/countries: JORDAN
Where can I look up RISPERIDONE-CHANELLE ORAL SOLUTION 1 MG/ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15227P or the exact product name RISPERIDONE-CHANELLE ORAL SOLUTION 1 MG/ML. The general register link does not preselect this product.
What are the source dates for this RISPERIDONE-CHANELLE ORAL SOLUTION 1 MG/ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this RISPERIDONE-CHANELLE ORAL SOLUTION 1 MG/ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15227P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)